Drug Type Chemical drugs |
Synonyms SYH2072 |
Target |
Action inhibitors |
Mechanism CYP11B2 inhibitors(Cytochrome P450 11B2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 1 | China | 15 Jan 2026 | |
| Hyperaldosteronism | IND Approval | China | 01 Feb 2026 | |
| Resistant hypertension | IND Approval | United States | 13 Jan 2026 |





